|
Age, years
|
41.2 (11.2)
|
40.6 (10.5)
|
41.8 (11.8)
|
.610
|
|
Male, n (%)
|
157 (98.1)
|
80 (97.6)
|
77 (96.3)
|
.990
|
|
BMI, kg/m2
|
23.2 (3.7)
|
23.5 (3.5)
|
22.9 (3.8)
|
.820
|
|
Etiology
|
|
TAO, n (%)
|
155 (96.9)
|
79 (96.3)
|
76 (97.4)
|
1.000
|
|
Eosinophilia, n (%)
|
1 (0.63)
|
0 (0)
|
1 (1.30)
|
.487
|
|
SLE, n (%)
|
3 (1.88)
|
2 (2.4)
|
1 (1.3)
|
1.000
|
|
Erythema nodosum, n (%)
|
1 (0.63)
|
1 (1.2)
|
0 (0)
|
1.000
|
|
Comorbidities
|
|
Smoking, n (%)
|
145 (90.6)
|
72 (87.8)
|
73 (93.6)
|
.210
|
|
Hypertension, n (%)
|
8 (5.0)
|
5 (6.1)
|
3 (3.8)
|
.720
|
|
Type II diabetes mellitus, n (%)
|
8 (5.0)
|
4 (4.9)
|
4 (5.1)
|
.990
|
|
Hyperlipidemia, n (%)
|
11 (6.88)
|
7 (8.5)
|
4 (5.1)
|
.394
|
|
Coronary artery disease, n (%)
|
3 (1.88)
|
2 (2.4)
|
1 (1.3)
|
.990
|
|
Treated limbs
|
|
Upper/lower extremity, n
|
5/155
|
3/79
|
2/76
|
.990
|
|
Right/left, n
|
86/74
|
44/38
|
42/36
|
.989
|
|
Ulcer only, n (%)
|
75 (46.9)
|
34 (41.5)
|
41 (52.6)
|
.160
|
|
Gangrene, n (%)
|
70 (43.8)
|
37 (4.1)
|
33 (42.3)
|
.720
|
|
Rutherford class
|
|
4, n (%)
|
15 (18.3)
|
11 (13.4)
|
4 (5.1)
|
.720
|
|
5, n (%)
|
145 (90.6)
|
71 (86.6)
|
74 (94.9)
|
.720
|
|
Medication history
|
|
Aspirin, n (%)
|
134 (83.8)
|
66 (80.5)
|
68 (87.2)
|
.251
|
|
Clopidogrel, n (%)
|
18 (11.3)
|
10 (12.2)
|
8 (11.2)
|
.698
|
|
Cilostazol, n (%)
|
61 (38.1)
|
32 (39.0)
|
29 (37.2)
|
.810
|
|
Prostaglandins, n (%)
|
124 (77.5)
|
61 (74.4)
|
63 (80.8)
|
.334
|
|
Warfarin, n (%)
|
6 (3.8)
|
4 (4.9)
|
2 (2.6)
|
.682
|
|
Rivaroxaban, n (%)
|
5 (3.1)
|
2 (2.4)
|
3 (3.8)
|
.676
|
|
Surgical history
|
|
Bypass, n (%)
|
18 (11.3)
|
11 (13.4)
|
7 (9.0)
|
.374
|
|
Endarterectomy, n (%)
|
5 (3.1)
|
3 (3.7)
|
2 (2.6)
|
1.000
|
|
PTA, n (%)
|
42 (26.3)
|
20 (24.2)
|
22 (28.2)
|
.584
|
|
Stenting, n (%)
|
16 (10.0)
|
8 (9.8)
|
8 (10.3)
|
.916
|
|
Thrombolysis, n (%)
|
52 (32.5)
|
28 (34.1)
|
24 (30.8)
|
.648
|
|
Sympathectomy, n (%)
|
7 (4.4)
|
2 (2.4)
|
5 (6.4)
|
.268
|
|
Surgical thrombectomy, n (%)
|
22 (13.8)
|
12 (14.6)
|
10 (12.8)
|
.739
|
|
Excimer laser thrombectomy, n (%)
|
7 (4.4)
|
2 (2.4)
|
5 (6.4)
|
.268
|
